The estimated Net Worth of Douglas S Mc Corkle is at least $14.8 Миллион dollars as of 29 December 2015. Douglas Corkle owns over 3,954 units of Regeneron Pharmaceuticals stock worth over $12,350,489 and over the last 17 years Douglas sold REGN stock worth over $2,408,720.
Douglas has made over 26 trades of the Regeneron Pharmaceuticals stock since 2007, according to the Form 4 filled with the SEC. Most recently Douglas exercised 3,954 units of REGN stock worth $205,727 on 29 December 2015.
The largest trade Douglas's ever made was exercising 35,000 units of Regeneron Pharmaceuticals stock on 14 February 2012 worth over $690,550. On average, Douglas trades about 5,496 units every 90 days since 2007. As of 29 December 2015 Douglas still owns at least 10,820 units of Regeneron Pharmaceuticals stock.
You can see the complete history of Douglas Corkle stock trades at the bottom of the page.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over $13,084,686,326 worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth $2,539,854,760 . The most active insiders traders include Sanofi, Pharma Ag Novartis и Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of $47,694,347. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth $381,400.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: